Publications by authors named "Joris Vos"

Claim this Profile
N
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.
Sabine E Breukers, Joleen J H Traets, Stan W van Dijk, Mercedes Machuca Ostos, Itske Fraterman, Joris L Vos

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics.
William Ang, Travis D Kerr, Ananya Kodiboyena, Cristina Valero, Joris L Vos

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination.
Karena Zhao, Joris Vos, Stanley Lam, Lillian A Boe, Daniel Muldoon

Nat Genet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data.
Seong-Keun Yoo, Conall W Fitzgerald, Byuri Angela Cho, Bailey G Fitzgerald, Catherine Han, Joris L Vos

Nat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.
Antoine Desilets, Joris L Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.
Joris L Vos, Joleen Jh Traets, Xiaohang Qiao, Iris M Seignette, Dennis Peters

JCI Insight· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.
Xin Lei, Daniël C de Groot, Marij J P Welters, Tom de Wit, Ellen Schrama, Joris L Vos

Cell Mol Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-cancer analysis of the microbiome in metastatic cancer.
Thomas W Battaglia, Iris L Mimpen, Joleen J H Traets, Arne van Hoeck, Laurien J Zeverijn, Joris L Vos

Cell· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Joris L Vos, Bharat Burman, Swati Jain, Conall W R Fitzgerald, Eric J Sherman

Nat Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Andrew Sangho Lee, Cristina Valero, Seong-Keun Yoo, Joris L Vos, Diego Chowell

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment.
Anne M van der Leun, Joleen J H Traets, Joris L Vos, Joris B W Elbers, Sanne Patiwael

Cancer Discov· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.
Cristina Valero, Mahdi Golkaram, Joris L Vos, Bin Xu, Conall Fitzgerald

J Clin Invest· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of immune equilibrium and escape in indolent and progressing tumors.
Abhinav Pandey, Maximilian Linxweiler, Fengshen Kuo, Jennifer L Marti, Benjamin Roman, Joris L Vos

Cancer Cell· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological imaging of the trapeziometacarpal joint: a historical and clinical perspective.
Kjell Van Royen, Arn Van Royen, Bert Vanmierlo, Chul Ki Goorens, Joris De Vos

J Hand Surg Eur Vol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma.
Hedda J van der Hulst, Joris L Vos, Renaud Tissier, Laura A Smit, Roland M Martens

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.
Joris L Vos, Charlotte L Zuur, Laura A Smit, Jan Paul de Boer, Abrahim Al-Mamgani

Eur J Nucl Med Mol Imaging· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Joris L Vos, Joris B W Elbers, Oscar Krijgsman, Joleen J H Traets, Xiaohang Qiao

Nat Commun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pronator sparing plate osteosynthesis in distal radius fractures: early functional outcome.
Kris Moens, Pieter Vansintjan, Geert De Loore, Joris De Vos

Acta Orthop Belg· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
Joris Vos, Pieter de Vey Mestdagh, David Colnot, Pepijn Borggreven, Claudia Orelio

Eur Arch Otorhinolaryngol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innervation of the elbow joint: Is total denervation possible? A cadaveric anatomic study.
Renata De Kesel, Francis Van Glabbeek, Dominique Mugenzi, Joris De Vos, Katrien Vermeulen

Clin Anat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis